Clinical trials
3 active studies led by Pulmair Medical, Inc., of 3 in all
Source: ClinicalTrials.gov, Studies with Pulmair Medical, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Pulmair Medical, Inc. in 3 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Pulmair Medical, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by Pulmair Medical, Inc., of 3 in all
Source: ClinicalTrials.gov, Studies with Pulmair Medical, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Pulmair Medical, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Pulmair Medical, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Pulmair Medical, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Pulmair Medical, Inc. is in.
Stories on the topics Pulmair Medical, Inc. works in.
Keeping the airway open is the first step in saving a life. More than half of deaths in low- and…
Read
More than 5 billion people lack access to safe, affordable medical oxygen. COVID-19 exposed gaps in…
Read
An estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Read